Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Rabies virus/RABV G/Glycoprotein Polyclonal Antibody

Catalog #:   PVV03901 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: O92284
Overview

Catalog No.

PVV03901

Species reactivity

Rabies virus (strain CVS-11) (RABV)

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Rabies virus/RABV G/Glyco(Leu30-Tyr459).

Tested applications

ELISA: 1:4000-1:8000, WB: 1:1000-1:4000

Target

Glycoprotein, G

Concentration

1.46 mg/ml

Purification

Purified by antigen affinity column.

Accession

O92284

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with G/Glycoprotein antibody (PVV03901) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 51 kDa
    Observed MW: 51 kDa
References

Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations., PMID:40398416

Development and validation of a blocking ELISA for measurement of rabies virus neutralizing antibody., PMID:40366189

Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs., PMID:40354406

Protection Against Rabies Induced by the Non-Replicative Viral Vectors MVA and Ad5 Expressing Rabies Glycoprotein., PMID:40284919

Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle-Targeting Lipid Nanoparticles in Mice., PMID:40266088

Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice., PMID:40251380

Assessing anti-rabies vaccine response in humans: A rapid and high-throughput adaptable, pseudovirus-based neutralization assay as an alternative to rapid fluorescent focus inhibition test (RFFIT)., PMID:40208858

Molecular basis of two broad-spectrum antibodies neutralizing rabies virus and other phylogroup-I lyssaviruses by blocking structural transition between the pleckstrin-homology and fusion domains in the glycoprotein., PMID:40154685

Construction and evaluation of recombinant rabies virus encoding three copies codon-optimized G genes as inactivated rabies vaccine in dogs and cats., PMID:40112690

A VSV-based oral rabies vaccine was sentineled by Peyer's patches and induced a timely and durable immune response., PMID:40022445

Metagenomic next-generation sequencing for etiological diagnosis of an unexpected rabies case with unclear exposure history., PMID:39994640

Changes in the dynamic characteristics of G-protein can alter the immune-protection efficacy of rabies virus vaccine., PMID:39982033

IL-16 exerts anti-rabies virus effects through CD9 on the surface of viral particles., PMID:39956243

Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers., PMID:39774967

Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations., PMID:39763725

Evaluation of the immune status of dogs vaccinated against rabies by an enzyme-linked immunosorbent assay using crude preparations of insect cells infected with a recombinant baculovirus encoding the rabies virus glycoprotein gene., PMID:39625902

Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases., PMID:39604401

Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis., PMID:39601104

A label-free optical biosensor-based point-of-care test for the rapid detection of Monkeypox virus., PMID:39550778

IL-7 promotes mRNA vaccine-induced long-term immunity., PMID:39550592

Randomized Controlled Trial of the Immunogenicity and Safety of a Serum-Free Purified Vero Rabies Vaccine (PVRV-NG2) Using a Simulated Postexposure Zagreb Regimen With Human Rabies Immunoglobulin in Adults in Thailand., PMID:39544495

Structural insight into rabies virus neutralization revealed by an engineered antibody scaffold., PMID:39471803

A novel inactivated oral rabies vaccine with the incorporation of U-OMP19 enhances the immunogenicity by reducing viral proteins degradation and activating dendritic cells in a mouse model., PMID:39471657

Protocol for constructing and characterizing recombinant vectored vaccines for rabies virus., PMID:39423123

Analysis of the antigenic and immunogenic properties of the native rabies virus glycoprotein purified by Lens culinaris lectin affinity chromatography., PMID:39413880

Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate., PMID:39366932

Analytical Methods for Evaluating the Immunogenicity of Recombinant Rabies Virus Glycoprotein Expressed in the Yeast Komagataella phaffii., PMID:39252192

A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice., PMID:39129566

Toward the Development of a Pan-Lyssavirus Vaccine., PMID:39066269

A Label-free Optical Biosensor-Based Point-of-Care Test for the Rapid Detection of Monkeypox Virus., PMID:39006424

Comparison of 4 laboratory tests for the detection of bovine rabies viral infection in Paraguay: fluorescent antibody test, rapid detection test, histologic lesions, and RT-PCR., PMID:38653733

Fc engineered anti-virus therapeutic human IgG1 expressed in plants with altered binding to the neonatal Fc receptor., PMID:38528347

Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial., PMID:38478634

Immune response after oral immunization of goats and foxes with an NDV vectored rabies vaccine candidate., PMID:38408125

Detection of Rabies IgG and IgM Antibodies Using the Rabies Indirect Fluorescent Antibody Test., PMID:38314801

A rabies mRNA vaccine with H270P mutation in its glycoprotein induces strong cellular and humoral immunity., PMID:38262810

A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs., PMID:38164714

Inactivated Recombinant Rabies Virus Displaying the Nipah Virus Envelope Glycoproteins Induces Systemic Immune Responses in Mice., PMID:38140162

Ante-mortem and Post-mortem Diagnosis Modalities and Phylogenetic Analysis of Rabies Virus in Domestic and Wild Animals of Gujarat, India., PMID:38031621

Single-injection subunit vaccine for rabies prevention using lentinan as adjuvant., PMID:37977452

An mRNA vaccine against rabies provides strong and durable protection in mice., PMID:37954577

A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses., PMID:37923181

Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice., PMID:37866995

A single immunization with core-shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs., PMID:37819147

Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial., PMID:37802090

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells., PMID:37786447

Genomic Surveillance of Rabies Virus in Georgian Canines., PMID:37766204

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals., PMID:37741831

Evaluation of an iELISA for detection and quantification of rabies antibodies in domestic dog sera., PMID:37716829

Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy., PMID:37638057

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Rabies virus/RABV G/Glycoprotein Polyclonal Antibody [PVV03901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only